CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.310

+0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SemiBull who wrote (374)	5/6/2001 2:47:12 PM
From: Craig N. Robinson	Read Replies (1) of 668

Explanation for "Non-Approvable" letter from the FDA? Hello, I used to own quite a bit of CBMI but eventually made a pre-merger purchase in my mother's portfolio and I haven't followed the stock much since. I did see the plunge the day the "Non-Approvable" letter was announced but was there ever a reason given for why the FDA rejected OP-1? I see such tremendous potential in CRIS that is in no way reflected in the stock price and I was curious why there wasn't a greater explanation of that rough short-term setback. Thanks, Craig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next